Along a TNF-paved road from dead parasites in red cells to cerebral malaria, and beyond

Parasitology

Volumn 136, Issue 12, 2009, Pages 1457-1468

  Clark, I A ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Babesia; Disease; Malaria; Mitochondria; TNF; Vaccine

Indexed keywords

BCG VACCINE; ENDOTOXIN; GAMMA INTERFERON; MALARIA VACCINE; RECOMBINANT TUMOR NECROSIS FACTOR; TUBERCULIN; TUMOR NECROSIS FACTOR ALPHA;

BABESIA; BABESIOSIS; BIOGENESIS; BRAIN MALARIA; BRAIN MITOCHONDRION; BRAIN PROTECTION; DISEASE COURSE; DRUG MECHANISM; ERYTHROCYTE; HOST PARASITE INTERACTION; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; NONHUMAN; PARASITE IDENTIFICATION; PATHOGENESIS; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REVIEW; VACCINATION;

ANIMALS; ERYTHROCYTES; HOST-PARASITE INTERACTIONS; MALARIA, CEREBRAL; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

BABESIA;

EID: 70350574196     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182009006088     Document Type: Review

References (115)

1. Abernathy, R. S., Bradley, G. M. and Spink, W. W. (1958). Increased susceptibility of mice with brucellosis to bacterial endotoxins. Journal of Immunology 81, 271-275.
2. Aggarwal, B. B., Kohr, W. J., Hass, P. E., Mo.at, B., Spencer, S. A., Henzel, W. J., Bringman, T. S., Nedwin, G. E., Goeddel, D. V. and Harkins, R. N. (1985). Human tumor necrosis factor: Production, purification, and characterization. Journal of Biological Chemistry 260, 2345-2354.
3. Ahmed, K., Al Matrouk, K. A., Martinez, G., Oishi, K., Rotimi, V. O. and Nagatake, T. (1999). Increased serum levels of interferon-gamma and interleukin-12 during human brucellosis. American Journal of Tropical Medicine and Hygiene 61, 425-427.
4. Anstey, N. M., Jacups, S. P., Cain, T., Pearson, T., Ziesing, P. J., Fisher, D. A., Currie, B. J., Marks, P. J. and Maguire, G. P. (2002). Pulmonary manifestations of uncomplicated falciparum and vivax malaria: Cough, small airways obstruction, impaired gas transfer, and increased pulmonary phagocytic activity. Journal of Infectious Diseases 185, 1326-1334.
5. Arsenijevic, D., Girardier, L., Seydoux, J., Chang, H. R. and Dulloo, A. G. (1997). Altered energy balance and cytokine gene expression in a murine model of chronic infection with Toxoplasma gondii. American Journal of Physiology 272, E908-E917.
6. Bajaj, M. S., Kuppuswamy, M. N., Manepalli, A. N. and Bajaj, S. P. (1999). Transcriptional expression of tissue factor pathway inhibitor, thrombomodulin and von Willebrand factor in normal human tissues. Thrombosis and Haemostasis 82, 1047-1052.
7. Bate, C. A., Taverne, J., Bootsma, H. J., Mason, R. C., Skalko, N., Gregoriadis, G. and Playfair, J. H. (1992). Antibodies against phosphatidylinositol and inositol monophosphate specifically inhibit tumour necrosis factor induction by malaria exoantigens. Immunology 76, 35-41.
8. Bauer, K. A., Cate, H. T., Barzeger, S., Spriggs, D. R., Sherman, M. L. and Rosenberg, R. D. (1989). Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans. Blood 74, 165-172.
9. Beattie, E. C., Stellwagen, D., Morishita, W., Bresnahan, J. C., Ha, B. K., Von Zastrow, M., Beattie, M. S. and Malenka, R. C. (2002). Control of synaptic strength by glial TNFalpha. Science 295, 2282-2285.
10. Bernardino, L., Agasse, F., Silva, B., Ferreira, R., Grade, S. and Malva, J. O. (2008). Tumor necrosis factor-alpha modulates survival, proliferation, and neuronal differentiation in neonatal subventricular zone cell cultures. Stem Cells 26, 2361-2371.
11. Berry, L. J., Moore, R. N., Goodrum, K. J. and Couch, R. E. (1977). Cellular requirements for enzyme inhibition by endotoxin in mice. Microbiology 1977 (ed. Schlessinger, D.), pp. 321-325. American Society of Microbiology, Washington D.C., USA.
12. Beutler, B. and Cerami, A. (1987). Cachectin-tumour necrosis factor: A cytokine that mediates injury initiated by invasive parasites. Parasitology Today 3, 345-346.
13. Beutler, B., Greenwald, D., Hulmes, J. D., Chang, M., Pan, Y.-C., Mathison, J., Ulevitch, R. and Cerami, A. (1985a). Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 316, 552-554.
14. Beutler, B., Mahoney, J., Le, T. N., Pekala, P. and Cerami, A. (1985b). Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells. Journal of Experimental Medicine 161, 984-995.
15. Bhutta, Z. A., Mansoorali, N. and Hussain, R. (1997). Plasma cytokines in paediatric typhoidal salmonellosis: Correlation with clinical course and outcome. Journal of Infection 35, 253-256.
16. Bour, E. S., Ward, L. K., Cornman, G. A. and Isom, H. C. (1996). Tumor necrosis factor-alpha-induced apoptosis in hepatocytes in long-term culture. American Journal of Pathology 148, 485-495.
17. Brealey, D., Karyampudi, S., Jacques, T. S., Novelli, M., Stidwill, R., Taylor, V., Smolenski, R. T. and Singer, M. (2004). Mitochondrial dysfunction in a longterm rodent model of sepsis and organ failure. American Journal of Physiology 286, R491-R497.
18. Budd, A., Alleva, L., Alshari., M., Koskinen, A., Smythe, V., Mullbacher, A., Wood, J. and Clark, I. (2007). Increased survival after gem.brozil treatment of severe mouse influenza. Antimicrobial Agents and Chemotherapy 51, 2965-2968.
19. Butcher, G. A., Bannister, L. H. and Mitchell, G. H. (1976). Immune damage to intracellular malaria parasites. Transactions of the Royal Society of Tropical Medicine and Hygiene 70, 11.
20. Butcher, G. A., Garland, T., Adjukiewicz, A. B. and Clark, I. A. (1990). Serum TNF associated with malaria in patients in the Solomon Islands. Transactions of the Royal Society of Tropical Medicine and Hygiene 84, 658-661.
21. Butcher, G. A., Mitchell, G. H. and Cohen, S. (1978). Antibody mediated mechanisms of immunity to malaria induced by vaccination with Plasmodium knowlesi merozoites. Immunology 34, 77-86.
22. Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N. and Williamson, B. (1975). An endotoxininduced serum factor that causes necrosis of tumors. Proceedings of the National Academy of Sciences, USA 72, 3666-3670.
23. Charles, P., Elliott, M. J., Davis, D., Potter, A., Kalden, J. R., Antoni, C., Breedveld, F. C., Smolen, J. S., Eberl, G., deWoody, K., Feldmann, M. and Maini, R. N. (1999). Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti- TNF-alpha therapy in rheumatoid arthritis. Journal of Immunology 163, 1521-1528.
24. Clark, I. A. (1973). The pathogenesis of St George disease of cattle. Research in Veterinary Science 14, 341-349.
25. Clark, I. A. (1978). Does endotoxin cause both the disease and parasite death in acute malaria and babesiosis? Lancet ii, 75-77.
26. Clark, I. A. (1979). Protection of mice against Babesia microti with cord factor, COAM, zymosan, glucan, Salmonella and Listeria. Parasite Immunology 1, 179-196.
27. Clark, I. A. (1982a). Correlation between susceptibility to malaria and babesia parasites and to endotoxin. Transactions of the Royal Society of Tropical Medicine and Hygiene 76, 4-7.
28. Clark, I. A. (1982b). Suggested importance of monokines in pathophysiology of endotoxin shock and malaria. Klinische Wochenschrift 60, 756-758.
29. Clark, I. A. (1987a). Cell-mediated immunity in protection and pathology of malaria. Parasitology Today 3, 300-305.
30. Clark, I. A. (1987b). Monokines and lymphokines in malarial pathology. Annals of Tropical Medicine and Parasitology 81, 577-585.
31. Clark, I. A. (2007). How TNF was recognized to be a key mechanism of disease. Cytokine and Growth Factor Reviews 18, 335-343.
32. Clark, I. A., Alleva, L. E., Mills, A. C. and Cowden, W. B. (2004). Pathogenesis in malaria and clinically similar conditions. Clinical Microbiology Reviews 17, 509-539.
33. Clark, I. A., Alleva, L. M., Budd, A. C. and Cowden, W. B. (2008a). Understanding the role of inflammatory cytokines in malaria and related diseases. Travel Medicine and Infectious Disease 6, 67-81.
34. Clark, I. A., Allison, A. C. and Cox, F. E. (1976). Protection of mice against Babesia and Plasmodium with BCG. Nature, London 259, 309-311.
35. Clark, I. A., Budd, A. C. and Alleva, L. M. (2008b). Sickness behaviour pushed too far - the basis of the syndrome seen in severe protozoal, bacterial and viral diseases and post-trauma. Malaria Journal 7, 208.
36. Clark, I. A., Budd, A. C., Alleva, L. M. and Cowden, W. B. (2006). Human malarial disease: A consequence of inflammatory cytokine release. Malaria Journal 5, 85.
37. Clark, I. A. and Chaudhri, G. (1988a). Tumor necrosis factor in malaria-induced abortion. American Journal of Tropical Medicine and Hygiene 39, 246-249.
38. Clark, I. A. and Chaudhri, G. (1988b). Tumour necrosis factor may contribute to the anaemia of malaria by causing dyserythropoiesis and erythrophagocytosis. British Journal of Haematology 70, 99-103.
39. Clark, I. A. and Cowden, W. B. (1989). Is TNF a key to acute infectious illness? Today's Life Science 1, 26-29.
40. Clark, I. A. and Cowden, W. B. (2003). The pathophysiology of falciparum malaria. Pharmacology and Therapeutics 99, 221-260.
41. Clark, I. A., Cowden, W. B., Butcher, G. A. and Hunt, N. H. (1987a). Possible roles of tumor necrosis factor in the pathology of malaria. American Journal of Pathology 129, 192-199.
42. Clark, I. A., Cox, F. E. and Allison, A. C. (1977a). Protection of mice against Babesia spp. and Plasmodium spp. with killed Corynebacterium parvum. Parasitology 74, 9-18.
43. Clark, I. A. and Gri.ths, M. J. (2007). The molecular basis of paediatric malarial disease. In Pediatric Infectious Diseases Revisited (ed. Schroten, H. and Wirth, S.), pp. 239-272. Birkhauser, Basel, Switzerland.
44. Clark, I. A., Hunt, N. H., Butcher, G. A. and Cowden, W. B. (1987b). Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole. Journal of Immunology 139, 3493-3496.
45. Clark, I. A., Richmond, J. E., Wills, E. J. and Allison, A. C. (1975). Immunity to intra-erythrocytic protozoa. Lancet ii, 1128-1129.
46. Clark, I. A., Richmond, J. E., Wills, E. J. and Allison, A. C. (1977b). Intra-erythrocytic death of the parasite in mice recovering from infection with Babesia microti. Parasitology 75, 189-196.
47. Clark, I. A. and Rockett, K. A. (1994). The cytokine theory of human cerebral malaria. Parasitology Today 10, 410-412.
48. Clark, I. A., Rockett, K. A. and Cowden, W. B. (1992). Possible central role of nitric oxide in conditions clinically similar to cerebral malaria. Lancet 340, 894-896.
49. Clark, I. A., Virelizier, J.-L., Carswell, E. A. and Wood, P. R. (1981). Possible importance of macrophage-derived mediators in acute malaria. Infection and Immunity 32, 1058-1066.
50. Collins, F. M. and Scott, M. T. (1974). Effect of Corynebacterium parvum on the growth of Salmonella enteritidis in mice. Infection and Immunity 9, 863-869.
51. Cox, F. E. G. (1970). Protective immunity between malaria parasites and piroplasms in mice. Bulletin of the World Health Organization 43, 325-336.
52. Crouser, E. D. (2004). Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome. Mitochondrion 4, 729-741.
53. Cumiskey, D., Butler, M. P., Moynagh, P. N. and O'Connor, J. J. (2007). Evidence for a role for the group I metabotropic glutamate receptor in the inhibitory effect of tumor necrosis factor-alpha on long-term potentiation. Brain Research 1136, 13-19.
54. d'Avila, J. C., Santiago, A. P., Amancio, R. T., Galina, A., Oliveira, M. F. and Bozza, F. A. (2008). Sepsis induces brain mitochondrial dysfunction. Critical Care Medicine 36, 1925-1932.
55. Diehl, A. M. and Rai, R. (1996). Review - regulation of liver regeneration by pro-inflammatory cytokines. Journal of Gastroenterology and Hepatology 11, 466-470. (Pubitemid 26151922)
56. Dubos, R. J. and Schaedler, R. W. (1957). Effect of cellular constituents of Mycobacteria on the resistance of mice to heterologous infection. Journal of Experimental Medicine 106, 703-709.
57. Emelyanov, V. V. (2001). Evolutionary relationship of Rickettsiae and mitochondria. FEBS Letters 501, 11-18.
58. Fairhurst, R. M. and Wellems, T. E. (2006). Modulation of malaria virulence by determinants of Plasmodium falciparum erythrocyte membrane protein-1 display. Current Opinion in Hematology 13, 124-130.
59. Ferguson, A. R., Christensen, R. N., Gensel, J. C., Miller, B. A., Sun, F., Beattie, E. C., Bresnahan, J. C. and Beattie, M. S. (2008). Cell death after spinal cord injury is exacerbated by rapid TNFalpha-induced tra.cking of GluR2-lacking AMPARs to the plasma membrane. Journal of Neuroscience 28, 11391-11400.
60. Fink, M. P. (2001). Cytopathic hypoxia. Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Critical Care Clinics 17, 219-237.
61. Genton, B., D'Acremont, V., Rare, L., Baea, K., Reeder, J. C., Alpers, M. P. and Muller, I. (2008). Plasmodium vivax and mixed infections are associated with severe malaria in children: A prospective cohort study from Papua New Guinea. PLoS Medicine 5, e127.
62. Giamarellos-Bourboulis, E. J., Kanellakopoulou, K., Pelekanou, A., Tsaganos, T. and Kotzampassi, K. (2008). Kinetics of angiopoietin-2 in serum of multitrauma patients: Correlation with patient severity. Cytokine 44, 310-313.
63. Giuliano, J. S., Lahni, P. M., Harmon, K., Wong, H. R., Doughty, L. A., Carcillo, J. A., Zingarelli, B., Sukhatme, V. P., Parikh, S. M. and Wheeler, D. S. (2007). Admission angiopoietin levels in children with septic shock. Shock 28, 650-654.
64. Good, M. F., Xu, H. J., Wykes, M. and Engwerda, C. R. (2005). Development and regulation of cellmediated immune responses to the blood stages of malaria: Implications for vaccine research. Annual Review of Immunology 23, 69-99.
65. Haden, D. W., Suliman, H. B., Carraway, M. S., Welty Wolf, K. E., Ali, A. S., Shitara, H., Yonekawa, H. and Piantadosi, C. A. (2007). Mitochondrial biogenesis restores oxidative metabolism during Staphylococcus aureus sepsis. American Journal of Respiratory and Critical Care Medicine 176, 768-777.
66. Halpern, B. N., Biozzi, G., Sti.el, C. and Mouton, D. (1966). Inhibition of tumour growth by abministration of killed Corynebacterium parvum. Nature, London 212, 853-854.
67. Hernandez Caselles, T. and Stutman, O. (1993). Immune functions of tumor necrosis factor. I. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6-induced proliferation depending on the concentration of mitogenic costimulation. Journal of Immunology 151, 3999-4012.
68. Hopkins, S. J. (2007). Central nervous system recognition of peripheral in.ammation: A neural, hormonal collaboration. Acta Biomedica 78 (Suppl. 1), 231-247.
69. Howard, J. G., Biozzi, G., Halpern, B. N., Sti.el, C. and Mouton, D. (1959). The effect of Mycobacterium tuberculosis (BCG) infection on the resistance of mice to bacterial endotoxin and Salmonella enteritidis infection. British Journal of Experimental Pathology 40, 281-290.
70. John, C. C., Panoskaltsis Mortari, A., Opoka, R. O., Park, G. S., Orchard, P. J., Jurek, A. M., Idro, R., Byarugaba, J. and Boivin, M. J. (2008). Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. American Journal of Tropical Medicine and Hygiene 78, 198-205.
71. Kawakami, M., Pekala, P. H., Lane, M. D. and Cerami, A. (1982). Lipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells. Proceedings of the National Academy of Sciences, USA 79, 912-916.
72. Kern, P., Hemmer, C. J., Van Damme, J., Gruss, H.-J. and Dietrich, M. (1989). Elevated tumour necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. American Journal of Medicine 87, 139-143.
73. Kwiatkowski, D., Hill, A. V. S., Sambou, I., Twumasi, P., Castracane, J., Manogue, K. R., Cerami, A., Brewster, D. R. and Greenwood, B. M. (1990). TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336, 1201-1204.
74. Langhorne, J., Butcher, G. A., Mitchell, G. H. and Cohen, S. (1979). Preliminary investigations on the role of the spleen in immunity to Plasmodium knowlesi malaria. In Role of the Spleen in the Immunology of Parasitic Diseases. Schwabe, Basel, Switzerland. UNDP/World Bank/WHO.
75. MacPherson, G. G., Warrell, M. J., White, N. J., Looareesuwan, S. and Warrell, D. A. (1985). Human cerebral malaria. A quantitative ultrastructural analysis of parasitised erythrocyte sequestration. American Journal of Pathology 119, 385-401.
76. Maegraith, B. G. (1938). Meningococcal broth culture .ltrates: Failure of protection experiments. British Journal of Experimental Pathology 19, 95-99.
77. Maegraith, B. G. (1954). Physiological aspects of protozoan infection. Annual Review of Microbiology 8, 273-288.
78. Maegraith, B. G. and Findlay, G. M. (1944). Oliguria in blackwater fever. Lancet ii, 403-404.
79. Maier, A. G., Rug, M., O'Neill, M. T., Brown, M., Chakravorty, S., Szestak, T., Chesson, J., Wu, Y., Hughes, K., Coppel, R. L., Newbold, C., Beeson, J. G., Craig, A., Crabb, B. S. and Cowman, A. F. (2008). Exported proteins required for virulence and rigidity of Plasmodium falciparum-infected human erythrocytes. Cell 134, 48-61.
80. Margulis, L. and Chapman, M. J. (1998). Endosymbioses: Cyclical and permanent in evolution. Trends in Microbiology 6, 342-345; discussion 345-346.
81. Murphy, S. C. and Breman, J. G. (2001). Gaps in the childhood malaria burden in Africa: Cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. American Journal of Tropical Medicine and Hygiene 64, 57-67.
82. Nakane, A., Yamada, K., Hasegawa, S., Mizuki, D., Mizuki, M., Sasaki, S. and Miura, T. (1999). Endogenous cytokines during a lethal infection with Listeria monocytogenes in mice. FEMS Microbiology Letters 175, 133-142.
83. Nisoli, E. and Carruba, M. O. (2006). Nitric oxide and mitochondrial biogenesis. Journal of Cell Science 119, 2855-2862.
84. Old, L. J., Clarke, D. A. and Benacerraf, B. (1959). E.ect of Bacillus Calmette Guérin infection on transplanted tumours in the mouse. Nature, London 184, 291-292.
85. Park, K. M., Yule, D. I. and Bowers, W. J. (2008). Tumor necrosis factor-alpha potentiates intraneuronal Ca2+ signaling via regulation of the inositol 1,4,5- trisphosphate receptor. Journal of Biological Chemistry 6, 33069-33079.
86. Pickering, M., Cumiskey, D. and O'Connor, J. J. (2005). Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Experimental Physiology 90, 663-670.
87. Pirsch, J. B., Mika, L. A. and van der Maaten, M. J. (1957). Hyperreactivity of Coxiella burnetii infected guines pigs to subsequent injections of bacterial endotoxins. Proceedings of the Society for Experimental Biology 96, 376-380.
88. Ranges, G. E., Zlotnik, A., Espevik, T., Dinarello, C. A., Cerami, A. and Palladino, M. A. (1988). Tumor necrosis factor alpha/cachectin is a growth factor for thymocytes. Synergistic interactions with other cytokines. Journal of Experimental Medicine 167, 1472-1478.
89. Raziuddin, S., Abdalla, R. E., El Awad, E. H. and Al Janadi, M. (1994). Immunoregulatory and proin.ammatory cytokine production in visceral and cutaneous leishmaniasis. Journal of Infectious Diseases 170, 1037-1040.
90. Rebel, V. I., Hartnett, S., Hill, G. R., Lazo Kallanian, S. B., Ferrara, J. L. and Sie., C. A. (1999). Essential role for the p55 tumor necrosis factor receptor in regulating hematopoiesis at a stem cell level. Journal of Experimental Medicine 190, 1493-1504.
91. Riazi, K., Galic, M. A., Kuzmiski, J. B., Ho, W., Sharkey, K. A. and Pittman, Q. J. (2008). Microglial activation and TNF{alpha} production mediate altered CNS excitability following peripheral in.ammation. Proceedings of the National Academy of Sciences, USA 105, 17151-17156.
92. Riley, M. V. and Maegraith, B. G. (1962). A factor in the serum of malaria-infected animals capable of inhibiting the in vitro oxidative metabolism of normal liver mitochondria. Annals of Tropical Medicine and Parasitology 55, 489-497.
93. Rook, G. A. W., Taverne, J., Leveton, C. and Steele, J. (1987). The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis. Immunology 62, 229-234.
94. Ross, R. (1911). The Prevention of Malaria. John Murray, London, UK.
95. Rubenstein, M., Mulholland, J. H., Je.ery, G. M. and Wol., S. M. (1965). Malaria-induced endotoxin tolerance. Proceedings of the Society for Experimental Biology and Medicine 118, 283-287.
96. Salvin, S. B., Ribi, E., Granger, D. L. and Youngner, J. S. (1975). Migration inhibitory factor and type II interferon in the circulation of mice sensitized with mycobacterial components. Journal of Immunology 114, 354-359.
97. Sanderson, C. J., Clark, I. A. and Taylor, G. A. (1975). Different effector cell types in antibody-dependent cell-mediated cytotoxicity. Nature, London 253, 376-377.
98. Schofield, L. and Hackett, F. (1993). Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites. Journal of Experimental Medicine 177, 145-153.
99. Smrkovski, L. L. and Larson, C. L. (1977). Effect of treatment with BCG on the course of visceral leishmaniasis in BALB/c mice. Infection and Immunity 16, 249-257.
100. Spriggs, D. R., Sherman, M. L., Michie, H., Arthur, K. A., Imamura, K., Wilmore, D., Frei, E. and Kufe, D. W. (1988). Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase 1 and pharmacologic study. Journal of the National Cancer Institute 80, 1039-1044.
101. Steinert, J. R., Kopp Scheinpflug, C., Baker, C., Challiss, R. A., Mistry, R., Haustein, M. D., Griffin, S. J., Tong, H., Graham, B. P. and Forsythe, I. D. (2008). Nitric oxide is a volume transmitter regulating postsynaptic excitability at a glutamatergic synapse. Neuron 60, 642-656.
102. Stellwagen, D. and Malenka, R. C. (2006). Synaptic scaling mediated by glial TNF-alpha. Nature, London 440, 1054-1059.
103. Suliman, H. B., Welty Wolf, K. E., Carraway, M., Tatro, L. and Piantadosi, C. A. (2004). Lipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis. Cardiovascular Research 64, 279-288.
104. Suliman, H. B., Welty Wolf, K. E., Carraway, M. S., Schwartz, D. A., Hollingsworth, J. W. and Piantadosi, C. A. (2005). Toll-like receptor 4 mediates mitochondrial DNA damage and biogenic responses after heat-inactivated E. coli. FASEB Journal 19, 1531-1533.
105. Suter, E., Ullman, G. E. and Hoffman, R. G. (1958). Sensitivity of mice to endotoxin after vaccination with BCG (Bacillus Calmette-Guérin). Proceedings of the Society for Experimental Biology 99, 167-169.
106. Swartzberg, J. E., Krahenbuhl, J. L. and Remington, J. S. (1975). Dichotomy between macrophage activation and degree of protection against Listeria monocytogenes and Toxoplasma gondii in mice stimulated with Corynebacterium parvum. Infection and Immunity 12, 1037-1043.
107. Takeda, K., Iwamoto, S., Sugimoto, H., Takuma, T., Kawatani, N., Noda, M., Masaki, A., Morise, H., Arimura, H. and Konno, K. (1986). Identity of differentiation inducing factor and tumour necrosis factor. Nature, London 323, 338-340.
108. Taverne, J., Bate, C. A. W. and Playfair, J. H. L. (1989). Induction of TNF in vitro as a model for the identification of toxic malaria antigens. Lymphokine Research 8, 317-322.
109. Taylor, T. E., Fu, W. J. J., Carr, R. A., Whitten, R. O., Mueller, J. G., Fosiko, N. G., Lewallen, S., Liomba, N. G. and Molyneux, M. E. (2004). Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nature Medicine 10, 143-145.
110. Tjitra, E., Anstey, N. M., Sugiarto, P., Warikar, N., Kenangalem, E., Karyana, M., Lampah, D. A. and Price, R. N. (2008). Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: A prospective study in Papua, Indonesia. PLoS Medicine 5, e128.
111. Tobinick, E. L., Gross, H., Weinberger, A. and Cohen, H. (2006). TNF-alpha modulation for treatment of Alzheimer's disease: A 6-month pilot study. MedGenMed Neurology and Neurosurgery 8, 25.
112. Turco, J. and Winkler, H. H. (1993). Role of the nitric oxide synthase pathway in inhibition of growth of interferon-sensitive and interferon-resistant Rickettsia prowazekii strains in L929 cells treated with tumor necrosis factor alpha and gamma interferon. Infection and Immunity 61, 4317-4325.
113. Witzenbichler, B., Westermann, D., Knueppel, S., Schultheiss, H. P. and Tschope, C. (2005). Protective role of angiopoietin-1 in endotoxic shock. Circulation 111, 97-105.
114. Xu, J., Qu, J., Cao, L., Sai, Y., Chen, C., He, L. and Yu, L. (2008). Mesenchymal stem cell-based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice. Journal of Pathology 214, 472-481.
115. Yeo, T. W., Lampah, D. A., Gitawati, R., Tjitra, E., Kenangalem, E., Piera, K., Price, R. N., Duffull, S. B., Celermajer, D. S. and Anstey, N. M. (2008). Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proceedings of the National Academy of Sciences, USA 105, 17097-17102.